‘We are approved by the FDA’s decision to Natroba are satisfied, ‘said Cooper Collins, President and Chief Executive Officer of pernix. ‘This product offers pernix a unique opportunity to promote a treatment that has been demonstrated in several clinical studies to be more effective than currently available therapies. We look forward to the launch of this innovative new prescription product to the pediatrics market through our established sales in the first half of 2011 ‘.
Head lice are the second most communicable disease in school children, according the joint cold.ii the U.S. Centers for disease Control and Prevention estimate that 6 to 12 million cases of head lice infestations every year, especially in children aged 3 to 12 years old. Head lice are tiny, wingless insects that. On the human scalp and spread between people by head – to-head contact or the sharing of hats, brushes or towels. Continue reading